2
|
Lu TC, Xiao WB, Tian HY, Qiu QZ, Zhu YT, Chen ZH, Li X, Chen YZ, Lei Y, Liu AL. Rapid Bacterial/Viral Infections Typing Strategy Using a Portable Dual-Channel Electrochemical Biosensor Based on One-Step Assembly of Immunomagnetic Beads. Anal Chem 2025; 97:5953-5964. [PMID: 40068971 DOI: 10.1021/acs.analchem.4c03442] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/26/2025]
Abstract
Amidst multiple epidemics, a rapid, sensitive, economical, and portable infection diagnosis strategy is crucial for primary medical care, particularly through the analysis of pathogen sources to determine appropriate antibiotic use. C-reactive protein (CRP) and serum amyloid A (SAA) are host-related biomarkers, and their combined detection can effectively distinguish between bacterial and viral infections, which holds great significance for the diagnosis of unknown pathogens. In this work, a portable dual-channel electrochemical biosensor based on a one-step assembly of immunomagnetic beads was proposed for the on-site combined detection of plasma CRP and SAA, which streamlined the operation and shortened the minimum detection time to less than 3 min. The biosensor exhibited excellent linearity in the detection of 3.125-1250 ng/mL CRP and 31.25-1250 ng/mL SAA, with detection limits of 0.91 and 12 ng/mL, respectively, falling within the clinically relevant reference range. Through simulated sample tests, the biosensor effectively distinguished between bacterial infection, viral infection, and healthy plasma samples. The actual sample tests demonstrated a high correlation and comparable medical value to enzyme-linked immunosorbent assay. Overall, this proposed strategy showed potential to aid in infection diagnosis and enable rapid combined detection of multiple biomarkers.
Collapse
Affiliation(s)
- Tai-Cheng Lu
- Department of Pharmaceutical Analysis, Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, The School of Pharmacy, Fujian Medical University, Fuzhou 350122, China
| | - Wen-Biao Xiao
- Department of Critical Care Medicine, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China
| | - Hui-Yun Tian
- Fujian Institute of Hematology, The Affiliated Union Hospital of Fujian Medical University, Fuzhou 350001, China
| | - Qing-Zhen Qiu
- Department of Pharmaceutical Analysis, Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, The School of Pharmacy, Fujian Medical University, Fuzhou 350122, China
| | - Yu-Ting Zhu
- Department of Pharmaceutical Analysis, Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, The School of Pharmacy, Fujian Medical University, Fuzhou 350122, China
| | - Zhen-Hua Chen
- Department of Pharmaceutical Analysis, Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, The School of Pharmacy, Fujian Medical University, Fuzhou 350122, China
| | - Xin Li
- Fujian Institute of Hematology, The Affiliated Union Hospital of Fujian Medical University, Fuzhou 350001, China
| | - Yuan-Zhong Chen
- Fujian Institute of Hematology, The Affiliated Union Hospital of Fujian Medical University, Fuzhou 350001, China
| | - Yun Lei
- Department of Pharmaceutical Analysis, Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, The School of Pharmacy, Fujian Medical University, Fuzhou 350122, China
| | - Ai-Lin Liu
- Department of Pharmaceutical Analysis, Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, The School of Pharmacy, Fujian Medical University, Fuzhou 350122, China
| |
Collapse
|
3
|
San Geroteo J, Levy M, Bailhache M, De Jorna C, Privat E, Gasmi O, Fuentes-Lopez M, Laoudi Y, Mazeghrane M, Malterre A, Bories P, Abdel Aal K, Arjoca I, Gaschignard J, Tanchaleune D, Minodier P, Audren F, Mazetier T, Quagliaro P, Raimond F, Sieng S, Robert B, Wohrer D, De Suremain N, Dauger S. Assessment of adherence to the 2020 Surviving Sepsis Campaign guidelines for fluid resuscitation in children with suspected septic shock in paediatric emergency departments: a prospective multicentre study. Arch Dis Child 2024; 109:636-641. [PMID: 38499323 DOI: 10.1136/archdischild-2023-325837] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/18/2023] [Accepted: 03/04/2024] [Indexed: 03/20/2024]
Abstract
BACKGROUND Paediatric sepsis is the leading cause of death in children under 5 years. No studies have evaluated the application of the Surviving Sepsis Campaign 2020 (SSC-2020) guidelines in paediatric emergency departments (PEDs). OBJECTIVE To assess physician adherence to the SSC-2020 fluid resuscitation guidelines in children with suspected septic shock in PEDs. METHODS This was a prospective multicentre observational study conducted in 21 French hospitals over 5 sequential weeks, between November 2021 and March 2022. Children with suspected septic shock and who received antimicrobial therapy within 72 hours were included. Primary outcome was SSC-2020 fluid resuscitation guidelines adherence (low 0-24%; moderate 25-74%; high 75-100%) according to: bolus volume of 10-20 mL/kg each, exclusive administration of balanced crystalloids at 1 and 24 hours of management, and initiation of fluid resuscitation within 1 hour of septic shock recognition. RESULTS 63 children were included. 10 (16%) children had severe sepsis and 2 (3%) met the definition of septic shock. Compared with the SSC-2020 guidelines, 43 (68%) patients received boluses of 10-20 mL/kg; fluid resuscitation was initiated within 1 hour of septic shock recognition in 42 (76%) cases; balanced crystalloids were the only fluids administrated in 35 (56%) and 34 (55%) children at 1 and 24 hours of management, respectively. Main barriers reported by physicians were difficult intravenous access (43%), lack of team training (29%), workload constraints (28%), and absence or out-of-date protocols (24%). CONCLUSIONS This study found high adherence for fluid resuscitation initiation but moderate adherence for bolus volume and fluid choice. TRIAL REGISTRATION NUMBER NCT05066464.
Collapse
Affiliation(s)
- Julian San Geroteo
- Pediatric Intensive Care Unit, Robert-Debré Mother-Child University Hospital, Paris, France
| | - Michael Levy
- Pediatric Intensive Care Unit, Robert-Debré Mother-Child University Hospital, Paris, France
| | - Marion Bailhache
- Pediatric Emergency Department, University Hospital Centre Bordeaux Pellegrin Hospital Group Children's Hospital, Bordeaux, France
| | - Claire De Jorna
- Pediatric Emergency Department, Lille University Hospital Center, Lille, France
| | - Elodie Privat
- Pediatric Emergency Department, Lille University Hospital Center, Lille, France
| | - Oussama Gasmi
- Pediatric Emergency Department, University Hospital Centre Nantes, Nantes, France
| | - Maria Fuentes-Lopez
- Pediatric Emergency Department, University Hospital Necker for Sick Children, Paris, France
| | - Yacine Laoudi
- Pediatric Emergency Department, Intermunicipal Hospital Centre Robert Ballanger, Aulnay sous Bois, France
| | - Mustapha Mazeghrane
- Pediatric Emergency Department, Centre Hospitalier Intercommunal André Grégoire, Montreuil, France
| | - Aline Malterre
- Pediatric Emergency Department, Centre Hospitalier Intercommunal de Créteil, Creteil, France
| | - Pauline Bories
- Pediatric Emergency Department, Hospital Louis-Mourier, Colombes, France
| | - Khaled Abdel Aal
- Pediatric Emergency Department, Hospital Centre Gonesse, Gonesse, France
| | - Iozefina Arjoca
- Pediatric Emergency Department, Centre Hospitalier François Quesnay, Mantes-la-Jolie, France
| | - Jean Gaschignard
- Pediatric Emergency Department, Groupement Hospitalier Nord Essonne, Longjumeau, France
| | - Davy Tanchaleune
- Pediatric Emergency Department, Hospital Bicetre, Le Kremlin-Bicetre, France
| | - Philippe Minodier
- Pediatric Emergency Department, Public Assistance-Hospitals of Marseille, Marseille, France
| | - Fabien Audren
- Pediatric Emergency Department, Intermunicipal Hospital Centre Villeneuve Saint Georges, Villeneuve Saint Georges, France
| | - Tifanny Mazetier
- Pediatric Emergency Department, Hospital Centre Victor Dupouy Argenteuil, Argenteuil, France
| | - Pauline Quagliaro
- Pediatric Emergency Department, Hospital Jean Verdier, Bondy, France
| | - Florence Raimond
- Pediatric Emergency Department, Hospital Antoine-Beclere, Clamart, France
| | - Soria Sieng
- Pediatric Emergency Department, Grand Hopital de l'Est Francilien, Jossigny, France
| | - Blandine Robert
- Pediatric Emergency Department, Centre Hospitalier de Pontoise, Pontoise, France
| | - Delphine Wohrer
- Pediatric Emergency Department, Robert-Debré Mother-Child University Hospital, Paris, France
| | - Nathalie De Suremain
- Pediatric Emergency Department, Armand-Trousseau Children's Hospital, Paris, France
| | - Stéphane Dauger
- Pediatric Intensive Care Unit, Robert-Debré Mother-Child University Hospital, Paris, France
| |
Collapse
|
4
|
Malorey D, Lorton F, Chalumeau M, Bourgoin P, Boussicault G, Chantreuil J, Gaillot T, Roué JM, Martinot A, Assathiany R, Saulnier JP, Caillon J, Grain A, Gras-Le Guen C, Launay E. Distribution, Consequences, and Determinants of Time to Antibiotics in Children With Community-Onset Severe Bacterial Infection: A Secondary Analysis of a Prospective Population-Based Study. Pediatr Crit Care Med 2023; 24:e441-e451. [PMID: 37260312 DOI: 10.1097/pcc.0000000000003306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
OBJECTIVES To describe the distribution, consequences and potential determinants of time to antibiotics administration in children with community-onset severe bacterial infections (COSBIs). DESIGN Secondary analysis of the available data from a prospective population-based study from 2009 to 2014. SETTING An administrative area in western France accounting for 13% of the national pediatric population. PATIENTS All children from 1 month to 16 years old admitted to a PICU or who died before admission and had a COSBI. INTERVENTIONS None. MEASUREMENTS AND MAIN RESULTS The time to antibiotics was divided into patient interval (from first signs of COSBI to the first medical consultation) and medical interval (from the first consultation to appropriate antibiotics administration). The association between the medical interval and child outcome was studied by a multinomial logistic regression model and the potential determinants of the patient and medical intervals were by a Cox proportional-hazards model. Of the 227 children included (median age 2.1 yr), 22 died (9.7%), and 21 (9.3%) had severe sequelae at PICU discharge. Median patient and medical intervals were 7.0 hours (interquartile range [IQR], 2.0-16.5 hr) and 3.3 hours (IQR, 1.1-12.2 hr), respectively. The last quartile of medical interval was not associated with death (adjusted odds ratio [aOR], 3.7; 95% CI, 0.8-17.5) or survival with severe sequelae (aOR, 1.3; 95% CI, 0.4-4.0) versus survival without severe sequelae. Patient interval was shorter in younger children (adjusted hazard ratio [aHR], 0.95; 95% CI, 0.92-0.99), and medical interval was reduced when the first consultation was conducted in a hospital (aHR, 1.5; 95% CI, 1.1-2.0) versus outpatient medicine. CONCLUSIONS For children with COSBI, we found no significant association between medical interval and mortality or severe sequelae. An initial hospital referral could help reduce the time to antibiotics in COSBIs.
Collapse
Affiliation(s)
- David Malorey
- Department of Pediatrics and Pediatric Emergency, Hôpital Femme Enfant Adolescent, CHU de Nantes, Nantes, France
- Inserm UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé), Centre of Research in Epidemiology and StatisticS (CRESS), Paris Descartes University, Paris, France
| | - Fleur Lorton
- Department of Pediatrics and Pediatric Emergency, Hôpital Femme Enfant Adolescent, CHU de Nantes, Nantes, France
- Inserm UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé), Centre of Research in Epidemiology and StatisticS (CRESS), Paris Descartes University, Paris, France
- Inserm 1413 CIC FEA, Nantes University Hospital, Nantes, France
- Department of General Pediatrics and Pediatric Infectious Diseases, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris, Paris Descartes University, Paris, France
- Department of Pediatric and Neonatal Critical Care, Femme Enfant Adolescent, CHU de Nantes, Nantes, France
- Department of Pediatric Critical Care, CHU d'Angers, Angers, France
- Department of Pediatric Critical Care, Hôpital Clocheville, CHU de Tours, Tours, France
- Department of Pediatric Critical Care, Hôpital Sud, CHU de Rennes, Rennes, France
- Department of Pediatric and Neonatal Critical Care, Hôpital Morvan, CHU de Brest, Brest, France
- University Lille, ULR 2694-METRICS: Evaluation des technologies de Santé et des pratiques médicales, CHU Lille, Lille, France
- Association pour la Recherche et l'Enseignement en Pédiatrie Générale (AREPEGE); Association Française de Pédiatrie Ambulatoire (AFPA), Cabinet de Pédiatrie, Issy-les-Moulineaux, France
- Department of Pediatric and Neonatal Critical Care, Tour Jean Bernard, CHU de Poitiers, Poitiers, France
- Department of Microbiology, Hôtel Dieu, CHU de Nantes, Nantes, France
- Pediatric Haematology and Oncology Department, University Hospital of Nantes, Nantes, France
- Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France
| | - Martin Chalumeau
- Inserm UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé), Centre of Research in Epidemiology and StatisticS (CRESS), Paris Descartes University, Paris, France
- Department of General Pediatrics and Pediatric Infectious Diseases, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris, Paris Descartes University, Paris, France
| | - Pierre Bourgoin
- Department of Pediatric and Neonatal Critical Care, Femme Enfant Adolescent, CHU de Nantes, Nantes, France
| | | | - Julie Chantreuil
- Department of Pediatric Critical Care, Hôpital Clocheville, CHU de Tours, Tours, France
| | - Théophile Gaillot
- Department of Pediatric Critical Care, Hôpital Sud, CHU de Rennes, Rennes, France
| | - Jean-Michel Roué
- Department of Pediatric and Neonatal Critical Care, Hôpital Morvan, CHU de Brest, Brest, France
| | - Alain Martinot
- University Lille, ULR 2694-METRICS: Evaluation des technologies de Santé et des pratiques médicales, CHU Lille, Lille, France
| | - Rémy Assathiany
- Association pour la Recherche et l'Enseignement en Pédiatrie Générale (AREPEGE); Association Française de Pédiatrie Ambulatoire (AFPA), Cabinet de Pédiatrie, Issy-les-Moulineaux, France
| | - Jean-Pascal Saulnier
- Department of Pediatric and Neonatal Critical Care, Tour Jean Bernard, CHU de Poitiers, Poitiers, France
| | - Jocelyne Caillon
- Department of Microbiology, Hôtel Dieu, CHU de Nantes, Nantes, France
| | - Audrey Grain
- Pediatric Haematology and Oncology Department, University Hospital of Nantes, Nantes, France
- Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France
| | - Christèle Gras-Le Guen
- Department of Pediatrics and Pediatric Emergency, Hôpital Femme Enfant Adolescent, CHU de Nantes, Nantes, France
- Inserm UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé), Centre of Research in Epidemiology and StatisticS (CRESS), Paris Descartes University, Paris, France
- Inserm 1413 CIC FEA, Nantes University Hospital, Nantes, France
- Department of General Pediatrics and Pediatric Infectious Diseases, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris, Paris Descartes University, Paris, France
- Department of Pediatric and Neonatal Critical Care, Femme Enfant Adolescent, CHU de Nantes, Nantes, France
- Department of Pediatric Critical Care, CHU d'Angers, Angers, France
- Department of Pediatric Critical Care, Hôpital Clocheville, CHU de Tours, Tours, France
- Department of Pediatric Critical Care, Hôpital Sud, CHU de Rennes, Rennes, France
- Department of Pediatric and Neonatal Critical Care, Hôpital Morvan, CHU de Brest, Brest, France
- University Lille, ULR 2694-METRICS: Evaluation des technologies de Santé et des pratiques médicales, CHU Lille, Lille, France
- Association pour la Recherche et l'Enseignement en Pédiatrie Générale (AREPEGE); Association Française de Pédiatrie Ambulatoire (AFPA), Cabinet de Pédiatrie, Issy-les-Moulineaux, France
- Department of Pediatric and Neonatal Critical Care, Tour Jean Bernard, CHU de Poitiers, Poitiers, France
- Department of Microbiology, Hôtel Dieu, CHU de Nantes, Nantes, France
- Pediatric Haematology and Oncology Department, University Hospital of Nantes, Nantes, France
- Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France
| | - Elise Launay
- Department of Pediatrics and Pediatric Emergency, Hôpital Femme Enfant Adolescent, CHU de Nantes, Nantes, France
- Inserm UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé), Centre of Research in Epidemiology and StatisticS (CRESS), Paris Descartes University, Paris, France
- Inserm 1413 CIC FEA, Nantes University Hospital, Nantes, France
- Department of General Pediatrics and Pediatric Infectious Diseases, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris, Paris Descartes University, Paris, France
- Department of Pediatric and Neonatal Critical Care, Femme Enfant Adolescent, CHU de Nantes, Nantes, France
- Department of Pediatric Critical Care, CHU d'Angers, Angers, France
- Department of Pediatric Critical Care, Hôpital Clocheville, CHU de Tours, Tours, France
- Department of Pediatric Critical Care, Hôpital Sud, CHU de Rennes, Rennes, France
- Department of Pediatric and Neonatal Critical Care, Hôpital Morvan, CHU de Brest, Brest, France
- University Lille, ULR 2694-METRICS: Evaluation des technologies de Santé et des pratiques médicales, CHU Lille, Lille, France
- Association pour la Recherche et l'Enseignement en Pédiatrie Générale (AREPEGE); Association Française de Pédiatrie Ambulatoire (AFPA), Cabinet de Pédiatrie, Issy-les-Moulineaux, France
- Department of Pediatric and Neonatal Critical Care, Tour Jean Bernard, CHU de Poitiers, Poitiers, France
- Department of Microbiology, Hôtel Dieu, CHU de Nantes, Nantes, France
- Pediatric Haematology and Oncology Department, University Hospital of Nantes, Nantes, France
- Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France
| |
Collapse
|